{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:32:46Z","timestamp":1761341566580,"version":"build-2065373602"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"DOI":"10.7759\/cureus.95348","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:27:02Z","timestamp":1761341222000},"source":"Crossref","is-referenced-by-count":0,"title":["Persistent Hepatocellular Secretory Failure Secondary to Flucloxacillin-Induced Liver Injury: A Case With Successful Response to Rifampicin"],"prefix":"10.7759","author":[{"given":"Syed Muhammad","family":"Hussaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Adjmal","family":"Rummun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijeta","family":"Rummun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyaulhaq","family":"Mustapha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12603","article-title":"Characterization and treatment of persistent hepatocellular secretory failure","volume":"35","author":"van Dijk R","year":"2015","unstructured":"van Dijk R, Kremer AE, Smit W, et al.. Characterization and treatment of persistent hepatocellular secretory failure. Liver Int. 2015, 35:1478-88. 10.1111\/liv.12603","journal-title":"Liver Int"},{"key":"ref2","article-title":"Current Diagnosis and Treatment in Gastroenterology, 2nd Edition","author":"Grendell JH","year":"2003","unstructured":"Grendell JH, McQuaid KR, Friedman SL. Current Diagnosis and Treatment in Gastroenterology, 2nd Edition. Lange Medical Books\/McGraw-Hill, New York; 2003."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200502000-00002","article-title":"Drug-induced acute liver failure","volume":"17","author":"Larrey D","year":"2005","unstructured":"Larrey D, Pageaux GP. Drug-induced acute liver failure. Eur J Gastroenterol Hepatol. 2005, 17:141-3. 10.1097\/00042737-200502000-00002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani N","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, et al.. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015, 148:1340-52.e7. 10.1053\/j.gastro.2015.03.006","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20081","article-title":"Hy's law","volume":"39","author":"Reuben A","year":"2004","unstructured":"Reuben A. Hy's law. Hepatology. 2004, 39:574-8. 10.1002\/hep.20081","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.11.012","article-title":"Liver disease associated with canalicular transport defects: current and future therapies","volume":"52","author":"Stapelbroek JM","year":"2010","unstructured":"Stapelbroek JM, van Erpecum KJ, Klomp LW, Houwen RH. Liver disease associated with canalicular transport defects: current and future therapies. J Hepatol. 2010, 52:258-71. 10.1016\/j.jhep.2009.11.012","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00472.x","article-title":"Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase","volume":"93","author":"Can\u00e7ado EL","year":"1998","unstructured":"Can\u00e7ado EL, Leit\u00e3o RM, Carrilho FJ, Laudanna AA. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase. Am J Gastroenterol. 1998, 93:1510-7. 10.1111\/j.1572-0241.1998.00472.x","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","unstructured":"Wendon, J, Cordoba J, Dhawan A, et al.. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017, 66:1047-81. 10.1016\/j.jhep.2016.12.003","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade RJ","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fern\u00e1ndez MC, et al.. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterol. 2005, 129:512-21 . 10.1053\/j.gastro.2005.05.006","journal-title":"Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15629","article-title":"Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure","volume":"36","author":"Shi M","year":"2021","unstructured":"Shi M, Sheng L, Lian M, Miao Q, Wang Q, Xiao X, Ma X. Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure. J Gastroenterol Hepatol. 2021, 36:3233-8. 10.1111\/jgh.15629","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425736-persistent-hepatocellular-secretory-failure-secondary-to-flucloxacillin-induced-liver-injury-a-case-with-successful-response-to-rifampicin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:27:02Z","timestamp":1761341222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425736-persistent-hepatocellular-secretory-failure-secondary-to-flucloxacillin-induced-liver-injury-a-case-with-successful-response-to-rifampicin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.95348","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}